Zyvox® Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008
- 31 December 2009
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 65 (4), 404-413
- https://doi.org/10.1016/j.diagmicrobio.2009.10.001
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosisInternational Journal of Antimicrobial Agents, 2006
- Trends in linezolid susceptibility patterns: report from the 2002–2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) ProgramInternational Journal of Antimicrobial Agents, 2005
- Multicentre evaluation of the in vitro activity of linezolid in the Western PacificJournal of Antimicrobial Chemotherapy, 2003
- Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox® antimicrobial potency study (ZAPS-Europe)Clinical Microbiology & Infection, 2002
- Linezolid-resistant enterococci: report of the first isolates in the United KingdomJournal of Antimicrobial Chemotherapy, 2002
- Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox® Antimicrobial Potency Study in Latin America (LA-ZAPS)The Brazilian Journal of Infectious Diseases, 2002
- A multicenter evaluation of linezolid antimicrobial activity in North AmericaDiagnostic Microbiology and Infectious Disease, 2002
- Oxazolidinone antibioticsThe Lancet, 2001
- Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparisonJournal of Antimicrobial Chemotherapy, 2001
- Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsJournal of Medicinal Chemistry, 1996